Search published articles


Showing 3 results for Cisplatin

Abdolrahman Dezfulian, Hayat Mombini, Shahla Zahiri, Farzaneh Dehgani , Abdolkarim Mansuri ,
Volume 5, Issue 4 (12-2002)
Abstract

Introduction: Cisplatin is a drug widely used as an antineoplastic drug for treatment of malignant tumors. But because of its side effects on the different systems especially kidney (nephrotoxic), the use of this drug is very limited. Clinical as well as, laboratory animal studies have supported this observations. In this research study we have used stereological technique (3-D) for finding the changes, due to nephrotoxic effect of this drug, in the number of glomeruli in kidney (numerical density and total number).
Materials and Methods: For experimental, 30 rats were separated by random sampling in to 3 groups of 10 animals cache. The first group received acute dose (7.5 mg/kg) of the drug (cisplatin) in serum physiology (experimental group). The second group received equivalent placebo dose in serum physiology through peritoneum (control). The third group received chronic dose (1.25 mg/kg) for 5 days, in serum physiology. All the 30 animals, after 96 hours, were anesthetized, dissected and their right kidneys were removed and placed in fixative (10% formalin). Whole kidney specimens were processed for stereology by special method of sectioning for physical disector and glomeruli number were counted.
Results: Number of glumeroli and numerical density was estimated for experimental groups (control, acute and chronic) was 31707, 30415 and 30802 as well 162, 119, and 140 respectively.
Conclusion: Stereological methods could be very useful for investigation of chemical drug effects in organs with good validity.
Assadollah Abbasi, Mojtaba Amani, Nowruz Najafzadeh, Mohammad Mazani,
Volume 16, Issue 11 (2-2014)
Abstract

Background: All-trans retinoic acid(RA), an active metabolite of vitamin A, is widely used to induce cell differentiation. It has significant effects on growth and proliferation of epithelial cells. It also causes cell cycle arrest in G0/G1 phase and induces the apoptosis. cisplatin, a chemotherapy compound that cross-linking to DNA, and leads to apoptosis, it is commonly used for treatment of ovarian, head and neck, esophageal, gastric cancers and melanoma. Recent studies showed that RA enhances cytotoxic effects of cisplatin on melanoma and ovarian cancer. Our literature review showed that there is no previous study on the effect of RA in combination with cisplatin on esophageal cancer, hence current study conducted to investigate such combination treatment on esophageal derived cell, KYSE-30.

Materials and Methods: KYSE30 cell line was cultured in presence of different concentration of RA alone and in combination with cisplatin. Then, cell death was investigated by colonogenic assay and acridine orange/ ethedium bromide staining.

Results: The results showed that RA concentrations &ge15µM cause differentiation of KYSE30 to squamous cell morphology, while lower concentrations decreases the colony formation (p&le0.05). These effects were also observed in combination with cisplatin and RA. The best effects on cell death were observed in 10 µM of RA of combination with 5 and 10 µg/ml of cisplatin.

Conclusion: The results suggest that low concentration of RA in combination with cisplatin are more effective than cisplatin alone in terms of apoptosis and necrosis of esophageal cancer, KYSE-30.


Mahsa Kavousi, Ehsan Rahimi, Jalil Fallah Mehrabadi,
Volume 22, Issue 2 (6-2019)
Abstract

Background and Aim: Lung cancer is one of the most contagious cancers in all of the world. Recently, several potential oncogenes and carcinogens have been identified, including EGFR, BRAF, KRAS and ALK genes. With due attention to the high prevalence of lung cancer, its death rate, the complications of chemotherapy and the efforts to find effective and less effective drugs, this study was done to investigate the effect of a plant extract so that results are available to manufacturing centers.
Materials and Methods: In this study, the effect of Eucalyptus extract and cisplatin on the expression of KRAS gene in A549 lung cancer cell line was investigated. To determine the cell survival, MTT was used and IC50 was determined. After determining IC50, the cells were exposed to less than IC50 concentrations of the extract and drug for 48 hours. Then, the amount of β-ACTIN and KRAS genes expressions in control and extract treated and drug treated groups were determined. For this purpose, a specific primers were designed for β- ACTIN and KRAS, and Real-Time PCR was be done.
Ethical Considerations: This study with research ethics code IR.IAU.East Tehran.REC.1396.3 has been approved by research ethics committee at Islamic Azad University, Tehran- East Branch, Iran.
Findings: The results showed that the amount of IC50 of the extract and drug was 8.75 and 1.77 mg/ml, respectively. In addition, the expression of genes in control and treated cells with extract and drug was compared. The expression of the KRAS gene relative to the reference gene in the cancer cell line treated with extract and drug, for 48 hours, was significantly decreased 2.89 and 9.25, respectively (p = 0).
Conclusion: Regarding the reduction of the relative gene expression in the A549 treated group, future studies on targeted lung cancer treatment can be promising and the potential for the use of plant compounds is more evident.


Page 1 from 1     

© 2025 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb